Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

NCT05841134 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

MSI-H Colorectal Cancer
Tislelizumab
Oxaliplatin
Capecitabine

Interventions

DRUG: Tislelizumab

Sponsor

The First Affiliated Hospital of Zhengzhou University